{"title":"Analysis of drug factors in 5-aminolevulinic acid photodynamic therapy for oral potentially malignant disorder.","authors":"Dandan Li, Zhujun Yu, Cheng Nie, Jianli Wang","doi":"10.7518/hxkq.2023.2023210","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to analyze the influence of drug factors on the efficacy of 5-aminolevulinic acid (ALA) photodynamic therapy for oral potentially malignant disorder to improve clinical efficacy and promote clinical rational drug use.</p><p><strong>Methods: </strong>Literature on the treatment of oral potentially malignant disorder by using ALA photodynamic therapy was collected and analyzed from PubMed, ISI Web of Knowledge database, CNKI, VIP, and Wanfang database.</p><p><strong>Results: </strong>A total of 690 cases were collected, with an average complete response rate of 65.94%. The groups treated with 16.8% methyl aminolevulinate cream, local topical, once a week, and pre-activation time of 2-4 hours were better than the other subgroups, with average complete response rates of 100%, 66.91%, 78.28%, and 77.54%, respectively.</p><p><strong>Conclusions: </strong>Drug factors have direct influence on the curative effect. The development of novel oral ALA formulations from the perspective of drug improvement is an important strategy to improve efficacy.</p>","PeriodicalId":94028,"journal":{"name":"Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10722451/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7518/hxkq.2023.2023210","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: This study aimed to analyze the influence of drug factors on the efficacy of 5-aminolevulinic acid (ALA) photodynamic therapy for oral potentially malignant disorder to improve clinical efficacy and promote clinical rational drug use.
Methods: Literature on the treatment of oral potentially malignant disorder by using ALA photodynamic therapy was collected and analyzed from PubMed, ISI Web of Knowledge database, CNKI, VIP, and Wanfang database.
Results: A total of 690 cases were collected, with an average complete response rate of 65.94%. The groups treated with 16.8% methyl aminolevulinate cream, local topical, once a week, and pre-activation time of 2-4 hours were better than the other subgroups, with average complete response rates of 100%, 66.91%, 78.28%, and 77.54%, respectively.
Conclusions: Drug factors have direct influence on the curative effect. The development of novel oral ALA formulations from the perspective of drug improvement is an important strategy to improve efficacy.
研究目的本研究旨在分析药物因素对5-氨基乙酰丙酸(ALA)光动力疗法治疗口腔潜在恶性疾病疗效的影响,以提高临床疗效,促进临床合理用药:方法:从PubMed、ISI Web of Knowledge数据库、CNKI、VIP和万方数据库中收集并分析利用ALA光动力疗法治疗口腔潜在恶性疾病的文献:共收集了 690 个病例,平均完全应答率为 65.94%。使用16.8%氨基乙酰丙酸甲酯乳膏、局部外用、每周一次、预激活时间为2-4小时的治疗组优于其他亚组,平均完全应答率分别为100%、66.91%、78.28%和77.54%:结论:药物因素对疗效有直接影响。结论:药物因素直接影响疗效,从药物改良角度开发新型口服 ALA 制剂是提高疗效的重要策略。